Daejeon, South Korea

Sang Rae Cho

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 5.9

ph-index = 5

Forward Citations = 71(Granted Patents)


Location History:

  • Daejeon, KR (2006 - 2018)
  • Seoul, KR (2009 - 2023)

Company Filing History:


Years Active: 2006-2023

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Sang Rae Cho in Breast Cancer Prognosis**

Introduction

Sang Rae Cho, a prolific inventor based in Daejeon, South Korea, has made significant strides in the field of medical technology, particularly in the prognosis of breast cancer. With a remarkable portfolio of 11 patents, Cho has developed innovative methods that promise to enhance the effectiveness of cancer treatment and provide critical information to healthcare professionals.

Latest Patents

Cho's latest inventions focus on predicting the prognosis of breast cancer patients. One of his notable patents describes a comprehensive method that includes several key steps: obtaining a biological sample from a patient, measuring specific mRNA expression levels, normalizing these levels, and ultimately predicting the prognosis based on the normalized data. This method is particularly effective in distinguishing between good and bad prognoses based on the expression levels of matrix metallopeptidase 11 (MMP11) and cluster of differentiation 2 (CD2).

Additionally, another significant patent offers a method for predicting the effectiveness of chemotherapy in breast cancer patients. This innovative approach allows for the measurement of gene expression levels in biological samples, which aids in determining the likely effectiveness of chemotherapy. Such advancements provide valuable insights into personalized treatment plans for patients, thereby improving outcomes.

Career Highlights

Sang Rae Cho has had a distinguished career in research and development. He has worked with esteemed institutions such as the Electronics and Telecommunications Research Institute, where he contributed to the advancement of technology in telecommunications. Later, his involvement with Gencurix Inc., a company specializing in cancer diagnosis, showcased his commitment to improving breast cancer treatment methodologies through innovative research and development.

Collaborations

Throughout his career, Cho has collaborated with fellow researchers, including Dae Seon Choi and Young Seob Cho. These partnerships have enriched his research output, enabling the development of groundbreaking methods that have the potential to transform cancer treatment.

Conclusion

Sang Rae Cho’s contributions to the field of breast cancer prognosis are invaluable. His pioneering patents, which leverage genetic information to provide better predictions for treatment efficacy, illustrate a significant leap forward in medical technology. As research in this area continues to evolve, Cho’s innovations are set to play a crucial role in the future of breast cancer diagnosis and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…